InsiderTrades

Form 4 for MGNX MACROGENICS INC

Accepted 2025-02-11 00:00:00 ET · period of report 2025-02-07 · accession 0001125345-25-000018 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-02-11 2025-02-08 MGNX Risser Eric Blasius COO M - OptEx — +11.2K 50.1K +29% —
D 2025-02-11 2025-02-08 MGNX Risser Eric Blasius COO F - Tax $2.60 -4,311 45.8K -9% -$11.2K
D 2025-02-11 2025-02-08 MGNX Risser Eric Blasius COO M - OptEx $0.00 -11.2K 22.3K -33% $0
DM 2025-02-11 2025-02-07 MGNX Risser Eric Blasius COO A - Grant $0.00 +140.0K 120.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-02-08 M A 11,168 — 50,068 D — — (F1) On February 8, 2024 the reporting person was granted 33,500 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.
2 Common Common Stock 2025-02-08 F D 4,311 $2.60 45,757 D — —
3 Derivative Restricted Stock Unit 2025-02-08 M D 11,168 $0.00 22,332 D — · — to — 11,168 Common Stock (F1) On February 8, 2024 the reporting person was granted 33,500 restricted stock units, 33% of which vested on February 8, 2025 and 33% of which will vest each year thereafter. Restricted stock units convert into the Company's stock on a one-for-one basis.
4 Derivative Restricted Stock Unit 2025-02-07 A A 20,000 $0.00 20,000 D — · — to — 20,000 Common Stock (F3) Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 33% of the total shares one year after the date of grant and 33% each year thereafter.
5 Derivative Employee Stock Option (right to buy) 2025-02-07 A A 120,000 $0.00 120,000 D $2.60 · — to 2035-02-07 120,000 Common Stock (F2) 12.5% of the shares underlying the grant become exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant become exercisable on the first day of each three-month period thereafter.